PL2262527T4 - Kompozycje do osiągania w surowicy pożądanych poziomów glejowego czynnika wzrostu 2 - Google Patents
Kompozycje do osiągania w surowicy pożądanych poziomów glejowego czynnika wzrostu 2Info
- Publication number
- PL2262527T4 PL2262527T4 PL09715322T PL09715322T PL2262527T4 PL 2262527 T4 PL2262527 T4 PL 2262527T4 PL 09715322 T PL09715322 T PL 09715322T PL 09715322 T PL09715322 T PL 09715322T PL 2262527 T4 PL2262527 T4 PL 2262527T4
- Authority
- PL
- Poland
- Prior art keywords
- compositions
- growth factor
- plasma levels
- achieving desired
- glial growth
- Prior art date
Links
- 102000048238 Neuregulin-1 Human genes 0.000 title 1
- 108090000556 Neuregulin-1 Proteins 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 230000036470 plasma concentration Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1883—Neuregulins, e.g.. p185erbB2 ligands, glial growth factor, heregulin, ARIA, neu differentiation factor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/51—Lyases (4)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/475—Assays involving growth factors
- G01N2333/4756—Neuregulins, i.e. p185erbB2 ligands, glial growth factor, heregulin, ARIA, neu differentiation factor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/285—Demyelinating diseases; Multipel sclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Cell Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US6758908P | 2008-02-29 | 2008-02-29 | |
| EP09715322.5A EP2262527B1 (en) | 2008-02-29 | 2009-03-02 | Compositions for achieving desired glial growth factor 2 plasma levels |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL2262527T3 PL2262527T3 (pl) | 2017-07-31 |
| PL2262527T4 true PL2262527T4 (pl) | 2017-07-31 |
Family
ID=41016663
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL09715322T PL2262527T4 (pl) | 2008-02-29 | 2009-03-02 | Kompozycje do osiągania w surowicy pożądanych poziomów glejowego czynnika wzrostu 2 |
| PL16182139.2T PL3120863T3 (pl) | 2008-02-29 | 2009-03-02 | Kompozycje do osiągnięcia pożądanych poziomów glejowego czynnika wzrostu 2 w osoczu |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL16182139.2T PL3120863T3 (pl) | 2008-02-29 | 2009-03-02 | Kompozycje do osiągnięcia pożądanych poziomów glejowego czynnika wzrostu 2 w osoczu |
Country Status (11)
| Country | Link |
|---|---|
| US (5) | US8410050B2 (pl) |
| EP (3) | EP2262527B1 (pl) |
| JP (2) | JP5697455B2 (pl) |
| CN (2) | CN102026651B (pl) |
| AU (1) | AU2009217606B2 (pl) |
| BR (1) | BRPI0908271A2 (pl) |
| CA (1) | CA2717193C (pl) |
| ES (2) | ES2613177T3 (pl) |
| PL (2) | PL2262527T4 (pl) |
| RU (3) | RU2530650C2 (pl) |
| WO (1) | WO2009108390A2 (pl) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5697455B2 (ja) | 2008-02-29 | 2015-04-08 | アコーダ セラピューティクス インコーポレイテッド | グリア成長因子２の所望の血漿レベルを達成するための方法 |
| ES2763184T3 (es) | 2008-07-17 | 2020-05-27 | Acorda Therapeutics Inc | Dosificación terapéutica de una neurregulina en el tratamiento o profilaxis de la insuficiencia cardíaca |
| ES2609927T3 (es) | 2008-08-15 | 2017-04-25 | Acorda Therapeutics, Inc. | Composiciones y métodos para tratamientos durante periodos no agudos después de lesiones neurológicas del SNC |
| CA2777243A1 (en) | 2009-10-14 | 2011-04-21 | Acorda Therapeutics, Inc. | Use of a neuregulin to treat peripheral nerve injury |
| MX2012013735A (es) * | 2010-05-28 | 2013-04-29 | Mind Nrg Sa | Isoformas de neuregulina, polipeptidos de neuregulina y usos de los mismos. |
| JP2013535507A (ja) * | 2010-08-13 | 2013-09-12 | ジョージタウン ユニバーシティ | Ｇｇｆ２および使用方法 |
| WO2013149163A1 (en) * | 2012-03-30 | 2013-10-03 | Acorda Therapeutics, Inc. | Use of neuregulin to treat peripheral nerve injury |
| WO2018056412A1 (ja) * | 2016-09-23 | 2018-03-29 | 国立大学法人大阪大学 | シュワン細胞分化促進剤及び末梢神経再生促進剤 |
| CN108653274B (zh) * | 2017-04-01 | 2022-09-16 | 鲁南制药集团股份有限公司 | 牛蒡子苷元在制备治疗骨髓损伤药物中的用途 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7319019B1 (en) | 1991-04-10 | 2008-01-15 | Acorda Therapeutics, Inc. | Glial mitogenic factors lacking an N-terminal signal sequence |
| US7135456B1 (en) | 1991-04-10 | 2006-11-14 | Acorda Therapeutics, Inc. | Glial mitogenic factors, their preparation and use |
| US5530109A (en) | 1991-04-10 | 1996-06-25 | Ludwig Institute For Cancer Research | DNA encoding glial mitogenic factors |
| US5716930A (en) | 1991-04-10 | 1998-02-10 | Ludwig Institute For Cancer Research | Glial growth factors |
| US7037888B1 (en) | 1992-04-03 | 2006-05-02 | Acorda Therapeutics, Inc. | Methods for treating muscle diseases and disorders |
| GB9217316D0 (en) * | 1992-08-14 | 1992-09-30 | Ludwig Inst Cancer Res | Schwann cell mitogenic factor,its preparation and use |
| US5912326A (en) | 1995-09-08 | 1999-06-15 | President And Fellows Of Harvard College | Cerebellum-derived growth factors |
| AU3003701A (en) * | 1999-11-19 | 2001-05-30 | Axxima Pharmaceuticals Ag | Inhibitors of helicobacter pylori induced gastrointestinal diseases |
| US20030232761A1 (en) | 2002-03-28 | 2003-12-18 | Hinke Simon A. | Novel analogues of glucose-dependent insulinotropic polypeptide |
| EP2354155B1 (en) * | 2003-05-16 | 2017-05-03 | Acorda Therapeutics, Inc. | Fusion Proteins for Treatment of CNS |
| WO2005079458A2 (en) * | 2004-02-19 | 2005-09-01 | The Regents Of The University Of California | ENHANCEMENT OF Th2-DEPENDENT AND INFLAMMATORY RESPONSE |
| WO2006084116A2 (en) | 2005-02-02 | 2006-08-10 | Nexuspharma Inc. | Amine derivative containing compositions and methods for the treatment of viral infections related to the etiology of cancer |
| US7776817B2 (en) | 2005-09-02 | 2010-08-17 | Morehouse School Of Medicine | Neuregulins for prevention and treatment of damage from acute assault on vascular and neuronal tissue and as regulators of neuronal stem cell migration |
| US20080003013A1 (en) * | 2006-06-30 | 2008-01-03 | Static Control Components, Inc. | Cartridge split rail clip |
| JP5697455B2 (ja) | 2008-02-29 | 2015-04-08 | アコーダ セラピューティクス インコーポレイテッド | グリア成長因子２の所望の血漿レベルを達成するための方法 |
| JP5431619B2 (ja) | 2010-04-01 | 2014-03-05 | ザ プロクター アンド ギャンブル カンパニー | 柔軟仕上げ剤 |
| JP2013535507A (ja) | 2010-08-13 | 2013-09-12 | ジョージタウン ユニバーシティ | Ｇｇｆ２および使用方法 |
-
2009
- 2009-03-02 JP JP2010548749A patent/JP5697455B2/ja not_active Expired - Fee Related
- 2009-03-02 US US12/380,760 patent/US8410050B2/en active Active
- 2009-03-02 CN CN200980114836.1A patent/CN102026651B/zh not_active Expired - Fee Related
- 2009-03-02 EP EP09715322.5A patent/EP2262527B1/en active Active
- 2009-03-02 CN CN201410709391.4A patent/CN104645315A/zh active Pending
- 2009-03-02 AU AU2009217606A patent/AU2009217606B2/en not_active Ceased
- 2009-03-02 WO PCT/US2009/001356 patent/WO2009108390A2/en active Application Filing
- 2009-03-02 ES ES09715322.5T patent/ES2613177T3/es active Active
- 2009-03-02 CA CA2717193A patent/CA2717193C/en active Active
- 2009-03-02 RU RU2010139906/15A patent/RU2530650C2/ru active
- 2009-03-02 EP EP16182139.2A patent/EP3120863B1/en active Active
- 2009-03-02 BR BRPI0908271A patent/BRPI0908271A2/pt not_active IP Right Cessation
- 2009-03-02 PL PL09715322T patent/PL2262527T4/pl unknown
- 2009-03-02 PL PL16182139.2T patent/PL3120863T3/pl unknown
- 2009-03-02 EP EP20173000.9A patent/EP3750551A1/en not_active Withdrawn
- 2009-03-02 ES ES16182139T patent/ES2811127T3/es active Active
-
2013
- 2013-03-29 US US13/853,386 patent/US9272015B2/en active Active
-
2014
- 2014-07-28 RU RU2014131265A patent/RU2687097C2/ru active
- 2014-10-17 JP JP2014212193A patent/JP5964920B2/ja not_active Expired - Fee Related
-
2016
- 2016-01-21 US US15/002,608 patent/US9744215B2/en active Active
-
2017
- 2017-07-25 US US15/658,967 patent/US10675331B2/en active Active
-
2019
- 2019-04-09 RU RU2019110452A patent/RU2019110452A/ru unknown
-
2020
- 2020-05-18 US US16/876,702 patent/US20210060128A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL2262527T4 (pl) | Kompozycje do osiągania w surowicy pożądanych poziomów glejowego czynnika wzrostu 2 | |
| IL228826A0 (en) | Low voc latex coating preparations | |
| ZA201103926B (en) | Stable sulfoximine-insecticide compositions | |
| SI2634232T1 (sl) | Sestavki | |
| GB0810404D0 (en) | Compositions | |
| HK1160728A1 (en) | Stable insecticide compositions and methods for producing same | |
| ZA201007247B (en) | Compositions comprising arnox-inhibitors for the inhibition of reactive oxygen species | |
| EP2421528A4 (en) | COMPOUNDS, COMPOSITIONS AND METHODS COMPRISING 1,3,4-OXADIAZOLE DERIVATIVES | |
| HK1159668A1 (en) | Multi-cure compositions | |
| GB0812041D0 (en) | Compositions | |
| GB0808537D0 (en) | Compositions | |
| GB0818804D0 (en) | Compositions | |
| EP2294199A4 (en) | COMPOSITIONS AND METHODS FOR ENHANCING PLANTS | |
| EP2288745A4 (en) | COATING COMPOSITIONS | |
| EP2266937A4 (en) | GAS GENERATING COMPOSITION | |
| GB0714298D0 (en) | Coating compositions | |
| EP2294198A4 (en) | METHODS AND COMPOSITIONS FOR ENHANCING PLANTS | |
| GB0816577D0 (en) | Growth factor | |
| EP2141991A4 (en) | COMPOSITIONS AND METHODS OF CHECKING EMERGENCY | |
| GB0618082D0 (en) | Growth factor | |
| GB0922424D0 (en) | Compounds, compositions and methods for controlling biofilms | |
| GB0922089D0 (en) | Compounds, compositions and methods for controlling biofilms | |
| GB0922087D0 (en) | Compounds, compositions and methods for controlling biofilms | |
| GB0922203D0 (en) | Controlling biofilms:compounds, compositions and methods | |
| GB0922205D0 (en) | Controlling biofilms:compounds, compositions and methods |